Navigation Links
New classification of eukaryotes has implications for AIDS treatment, agriculture and beyond

New classification conveys important information about the biochemistry and metabolism of disease-causing organisms. The new classification recognizes 6 major clusters of organisms, rather than the 4 traditional Kingdoms.

Here are three examples. 1) Pneumocystis, an opportunistic pathogen causing mortality in AIDS patients and immunocompromised individuals, is now known to be a fungus, indicating a different treatment regimen is needed. 2) Phytophtora, an organism causing potato blight, such as the one that caused the Irish famine in the 19th century, is now known not to be a fungus, which explains why fungicides are not effective treatments. 3) Plasmodium, the causative agent of malaria, is now known to share ancestry with photosynthetic organisms and has a vestigial chloroplast, called the apicoplast. This knowledge opens exciting possibilities for novel drug therapies.

The clusters are 1) the Opisthokonta, grouping the animals, fungi, choanoflagellates, and Mesomycetozoa; 2) the Amoebozoa, grouping most traditional amoebae, slime moulds, many testate amoebae, some amoebo-flagellates, and several species without mitochondria; 3) the Excavata, grouping oxymonads, parabasalids, diplomonads, jakobids, and several other genera of heterotrophic flagellates, and possibly including the Euglenozoa and Heterolobosea; 4) the Rhizaria, grouping the Foraminifera, most of the traditional Radiolaria, and the Cercozoa with filose pseudopodia, such as many amoebo-flagellates and some testate amoebae; 5) the Archaeplastida, grouping the Glaucophyta, red algae, green algae, and Plantae; 6) the Chromalveolata, grouping the Alveolata (including ciliates, the dinoflagellates, and the Apicomplexa), cryptophytes, haptophytes, and stramenopiles (including brown algae, the diatoms, many zoosporic fungi, opalinids, amongst others).

Finally, the authors noted that they "adopted a hierarchical system without formal rank designations, such as "class," "sub-class," "su
'"/>

Source:Blackwell Publishing Ltd.


Page: 1 2

Related biology news :

1. An entropy-based gene selection method for cancer classification using microarray data
2. Towards precise classification of cancers based on robust gene functional expression profiles
3. Lipids get new comprehensive classification system
4. New book expands biological classifications to account for alien life
5. New understanding of COX-1 and COX-2 enzymes could revise classification of pain meds
6. Biochemists report discovery of structure of major piece of telomerase; implications for cancer
7. Findings have implications for tracking disease, drugs at the molecular level
8. Science study holds implications for gene therapy and stem cell biology
9. Muscle repair: Making a good system better, faster; implications for aging, disease
10. Inside rocks, implications for finding life on Mars
11. How mammals fuel milk production may have implications for cancer
Post Your Comments:
(Date:6/30/2015)... -- To bolster its efforts and commitment to fighting cyber ... addition of two new team members. ... David Raviv will act as head of strategic alliances. ... providing the most secure solutions for the enterprise market. ... Technologies, a provider of security and management products, which was ...
(Date:6/26/2015)... ATL Technology, LLC, a top provider of electromechanical contract manufacturing ... headquartered in Springville, Utah , has announced ... corporation with locations in Santa Clara, CA ... ). This acquisition will incorporate MedConx,s manufacturing facility ... existing facility in Costa Rica , resulting ...
(Date:6/25/2015)... June 25, 2015  TAKE Solutions Ltd., a global ... the United States Patent and Trademark Office (USPTO) for ... leverages TAKE Solutions, Clinical Accelerators to reduce the time ... compared to standardization without the accelerators), thus reducing time ... At the heart of the patented Clinical ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2TAKE Solutions Awarded Patent By USPTO 2
... to tailored treatmentsWhen it comes to inflammation, too much ... severely injured patients, this normal healing process can develop ... and multiple organ failure. How and why inflammation turns ... can't accurately predict how each injured patient will fare. ...
... Editor : Be sure to check out the complete ... languages. , There is new evidence that adult HIV infection ... behaviour to prevent infection—such as increased use of condoms, delay ... key part in these declines. The new UN report also ...
... infection is inversely correlated with the presence of plasmacytoid dendritic ... the major producers of type 1 interferon in the body. ... of HIV. In a paper appearing online on October ... of the Journal of Clinical Investigation, Nina Bhardwaj and colleagues ...
Cached Biology News:Study reveals genomics of inflammation from severe injury 2Study reveals genomics of inflammation from severe injury 32005 AIDS figures released by WHO and UNAIDS 22005 AIDS figures released by WHO and UNAIDS 32005 AIDS figures released by WHO and UNAIDS 4
(Date:7/28/2015)... LONDON , July 29, 2015 ... on acquiring, rapidly developing and commercialising ... human health   Highly experienced management team; ...     Mereo BioPharma Group Ltd ... successfully raised $119m ( c. £76.5m), gross, from blue ...
(Date:7/28/2015)... 28, 2015 People with a common form ... significant and sometimes profound improvements in their hearing and ... to a new multicenter study led by specialists at ... described online ahead of print in the journal The Laryngoscope ... clinics in the United States ...
(Date:7/28/2015)... 21, 2015 Research and Markets ( ... "Biomedical Refrigerators and Freezers Market - Global ... 2014 - 2022" report to their offering. ... freezers market has been segmented based on applications: ... and others. The others segment includes applications of ...
(Date:7/28/2015)... July 28, 2015  Kerastem Technologies announce that the ... U.S. FDA Center For Biologics Evaluation and Research (CBER) ... a clinical trial investigating the safety and feasibility of ... early male pattern baldness (androgenic alopecia). The ... initial clinical work in Europe ...
Breaking Biology Technology:Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 5Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 6Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 7Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 8Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 9Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 10Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 11Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 3Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 2Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 3Kerastem Receives Conditional Approval from FDA for Alopecia Trial 2
... presents to a doctor, many assessments have to be made ... is unglamorously called managing the patient. , ,During residency, which ... us believe, one of the most important judgment calls that ... This is not in the sense that the patient ...
... Wis . - In the first indication of how they ... Cardinal Health say they are excited about the ... a merger agreement between Cardinal Health and Viasys Healthcare, Cardinal ... $1.5 billion, pending approval from both companies' boards of directors. ...
... family-focused Web hosting and social networking site Famster.com ... to a subscription-only business model. The move comes in response ... ,We find that families do not want to have their ... ,Interestingly, Web businesses have yet to find whether families - ...
Cached Biology Technology:Barriers will not stop convergence of medical technologies 2Barriers will not stop convergence of medical technologies 3Barriers will not stop convergence of medical technologies 4Barriers will not stop convergence of medical technologies 5Barriers will not stop convergence of medical technologies 6Barriers will not stop convergence of medical technologies 7Cardinal Health likes growth potential of Viasys NeuroCare Group 2Cardinal Health likes growth potential of Viasys NeuroCare Group 3Delivering value instead of advertising - what a concept! 2Delivering value instead of advertising - what a concept! 3
...
...
... III) from E. coli is an endoribonuclease ... dsRNA fragments that have 2-base, 3'-overhangs. ... fragments of 12-15 bp. RNase III ... ribonucleotides as well as DuraScript™ RNA, produced ...
Mouse monoclonal [6911] to E. coli K99 pilus ( Abpromise for all tested applications)....
Biology Products: